Injection of Local Anesthetic to Trocar Insertion Sites After Laparoscopy
Pain, Postoperative
About this trial
This is an interventional prevention trial for Pain, Postoperative focused on measuring Local, Anesthesia, Pain, Laparoscopic hysterectomy, Trocar site, Port site
Eligibility Criteria
Inclusion Criteria:
- Patients who are scheduled for a laparoscopic hysterectomy for benign indications at the Department of Obstetrics & Gynecology's Division of Minimally Invasive Surgery at Milton S. Hershey Medical Center will be included.
Exclusion Criteria:
- Patients who are scheduled for a hysterectomy through the vaginal or abdominal approach will be excluded. Patients with preoperative indications of endometriosis or chronic pelvic pain will also be excluded since these patients could potentially have higher thresholds of pain.
Sites / Locations
- Penn State Milton S. Hershey Medical Center
Arms of the Study
Arm 1
Arm 2
No Intervention
Active Comparator
No Treatment
Bupivacaine
The "No Treatment" group includes patients undergoing laparoscopic hysterectomy without local infiltration of bupivacaine.
The "Bupivacaine Arm" includes all patients who will receive bupivacaine injection on their trocar sites after the laparoscopic hysterectomy is completed. Bupivacaine (0.25%) will be injected through the closed incisions ensuring subcutaneous tissue, fascia, muscle and pre-peritoneal space of the trocar incision sites are infiltrated. All incisions 8 mm and greater are injected with 10 cc while all incisions 5 mm or less are infiltrated with 5 cc.